Astghik Voskanyan, MD, Immune Oncology Research Institute (IMMONC), Yerevan, Armenia, discusses her work towards international collaboration to improve the treatment and diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Data from 62 patients have been collected so far, with ongoing efforts to gather more. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.